Bio-Rad Laboratories, Inc. (BIO)
280.09
+9.77
(+3.61%)
USD |
NYSE |
Jun 24, 16:00
280.19
+0.10
(+0.04%)
After-Hours: 18:10
Bio-Rad Laboratories Research and Development Expense (Quarterly) : 62.90M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 62.90M |
| December 31, 2025 | 66.00M |
| September 30, 2025 | 70.60M |
| June 30, 2025 | 60.80M |
| March 31, 2025 | 60.20M |
| December 31, 2024 | 67.80M |
| September 30, 2024 | 61.10M |
| June 30, 2024 | 59.30M |
| March 31, 2024 | 63.98M |
| December 31, 2023 | 62.21M |
| September 30, 2023 | 28.74M |
| June 30, 2023 | 63.94M |
| March 31, 2023 | 70.75M |
| December 31, 2022 | 66.40M |
| September 30, 2022 | 66.81M |
| June 30, 2022 | 64.35M |
| March 31, 2022 | 59.54M |
| December 31, 2021 | 68.92M |
| September 30, 2021 | 64.28M |
| June 30, 2021 | 65.29M |
| March 31, 2021 | 56.91M |
| December 31, 2020 | 65.76M |
| September 30, 2020 | 59.55M |
| June 30, 2020 | 51.98M |
| March 31, 2020 | 48.90M |
| Date | Value |
|---|---|
| December 31, 2019 | 50.97M |
| September 30, 2019 | 48.04M |
| June 30, 2019 | 50.02M |
| March 31, 2019 | 47.58M |
| December 31, 2018 | 53.07M |
| September 30, 2018 | 49.74M |
| June 30, 2018 | 47.75M |
| March 31, 2018 | 49.43M |
| December 31, 2017 | 76.04M |
| September 30, 2017 | 62.08M |
| June 30, 2017 | 62.59M |
| March 31, 2017 | 49.45M |
| December 31, 2016 | 57.54M |
| September 30, 2016 | 49.92M |
| June 30, 2016 | 49.77M |
| March 31, 2016 | 48.59M |
| December 31, 2015 | 55.89M |
| September 30, 2015 | 43.34M |
| June 30, 2015 | 46.55M |
| March 31, 2015 | 47.20M |
| December 31, 2014 | 59.29M |
| September 30, 2014 | 52.79M |
| June 30, 2014 | 55.72M |
| March 31, 2014 | 52.54M |
| December 31, 2013 | 55.85M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 126.00M |
| Thermo Fisher Scientific, Inc. | 336.00M |
| Illumina, Inc. | 240.00M |
| Danaher Corp. | 387.00M |
| Pacific Biosciences of California, Inc. | 19.61M |